Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis
2017-002726-20Phase 4
- Sponsor
- Alcon Inc.
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of olopatadine in perennial rhinitis, sponsored by Alcon Inc. Primary endpoint: Clinically relevant change in nasal examination parameters.
02
Drugs
olopatadine
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on 2017-002726-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002726-20.